Robert Renninger - Mar 3, 2025 Form 4/A - Amendment Insider Report for Athira Pharma, Inc. (ATHA)

Role: SVP, Finance and Accounting
Signature: /s/ Mark Worthington Attorney-in-Fact for Robert Renninger
Stock symbol: ATHA
Transactions as of: Mar 3, 2025
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 3/12/2025, 05:20 PM
Date Of Original Report: Mar 4, 2025
Previous filing: Jan 3, 2025
Next filing: Jul 2, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATHA	Stock Option (Right to Buy)	Award	$0	+73.4K		$0.00	73.4K	Mar 3, 2025	Common Stock	73.4K	$0.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One fourth (1/4th) of shares subject to the option shall be scheduled to vest on the one (1)-year anniversary of the grant date, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option each month thereafter on the same day of the month as the grant date subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.

Content

One fourth (1/4th) of shares subject to the option shall be scheduled to vest on the one (1)-year anniversary of the grant date, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option each month thereafter on the same day of the month as the grant date subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.

Remarks:

This amendment is being made solely to correct the vesting schedule of the referenced stock option award, which vesting schedule was erroneously reported in the original Form 4 filed on March 4, 2025.